MethodsBioinformaticsPeer-reviewed journal article
In silico design of ligand triggered RNA switches
Sven FindeißiD, Stefan HammeriD, Michael T. WolfingeriD, Felix KühnliD, Christoph Flamm AiD, Ivo L. HofackeriD
Abstract
This contribution sketches a work flow to design an RNA switch that is able to adapt two structural conformations in a ligand-dependent way. A well characterized RNA aptamer, i. e., knowing its Kd and adaptive structural features, is an essential ingredient of the described design process. We exemplify the principles using the well-known theophylline aptamer throughout this work. The aptamer in its ligand-binding competent structure represents one structural conformation of the switch while an alternative fold that disrupts the binding-competent structure forms the other conformation. To keep it simple we do not incorporate any regulatory mechanism to control transcription or translation. We elucidate a commonly used design process by explicitly dissecting and explaining the necessary steps in detail. We developed a novel objective function which specifies the mechanistics of this simple, ligand-triggered riboswitch and describe an extensive in silico analysis pipeline to evaluate important kinetic properties of the designed sequences. This protocol and the developed software can be easily extended or adapted to fit novel design scenarios and thus can serve as a template for future needs.
- Citations
- 19
- FWCI
- 0.98
- Field percentile
- top 26%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Automated design of highly diverse riboswitches
M. J. Wu, J. O. Andreasson, … R. Das·bioRxiv·Apr 9, 2019
- Designing molecular RNA switches with Restricted Boltzmann machines
Jorge Fernández-de-Cossio-Díaz, Pierre Hardouin, … Simona Cocco·Nature CommunicationsPeer-reviewed·Dec 18, 2025
- Single-base substitutions switch RNA tertiary allostery between positive and negative coupling.
Alabi Oladeji, Brandon G. Kircher, Joseph David Yesselman·bioRxiv·Aug 11, 2026
- Mechanistic Analysis of Riboswitch Ligand Interactions Provides Insights into Pharmacological Control over Gene Expression
Shaifaly Parmar, Desta Doro Bume, … John S. Schneekloth·Nature CommunicationsPeer-reviewed·Sep 17, 2024
- Small molecule-controlled gene expression: Design of drug-like high affinity small molecule modulators of a custom-made riboswitch
Vera Hedwig, Maike Spöring, … Oliver Hucke·bioRxiv·Jan 21, 2025
- Beyond Plug and Pray: Context Sensitivity and in silico Design of Artificial Neomycin Riboswitches
Christian Günzel, Felix Kühnl, … Mario Mörl·RNA BiologyPeer-reviewed·Sep 3, 2020